Northern Trust’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-897,455
| Closed | -$76.2M | – | 4336 |
|
|
2019
Q4 | $76.2M | Sell |
897,455
-64,470
| -7% | -$4.3M | 0.02% | 717 |
|
|
2019
Q3 | $48.1M | Buy |
961,925
+89,020
| +10% | +$3.55M | 0.01% | 1006 |
|
|
2019
Q2 | $31.8M | Buy |
872,905
+10,796
| +1% | +$352K | 0.01% | 1344 |
|
|
2019
Q1 | $24.1M | Buy |
862,109
+7,721
| +0.9% | +$182K | 0.01% | 1532 |
|
|
2018
Q4 | $16.4M | Sell |
854,388
-78,286
| -8% | -$1.82M | ﹤0.01% | 1746 |
|
|
2018
Q3 | $27.9M | Buy |
932,674
+26,169
| +3% | +$986K | 0.01% | 1508 |
|
|
2018
Q2 | $33.3M | Buy |
906,505
+14,879
| +2% | +$483K | 0.01% | 1357 |
|
|
2018
Q1 | $29.4M | Buy |
891,626
+3,748
| +0.4% | +$117K | 0.01% | 1401 |
|
|
2017
Q4 | $24.3M | Sell |
887,878
-16,260
| -2% | -$501K | 0.01% | 1563 |
|
|
2017
Q3 | $33.5M | Sell |
904,138
-8,012
| -0.9% | -$295K | 0.01% | 1300 |
|
|
2017
Q2 | $34.7M | Buy |
912,150
+38,142
| +4% | +$1.7M | 0.01% | 1235 |
|
|
2017
Q1 | $42.7M | Buy |
874,008
+23,571
| +3% | +$1.08M | 0.01% | 1041 |
|
|
2016
Q4 | $28.9M | Buy |
850,437
+8,209
| +1% | +$291K | 0.01% | 1315 |
|
|
2016
Q3 | $31.8M | Sell |
842,228
-5,418
| -0.6% | -$204K | 0.01% | 1200 |
|
|
2016
Q2 | $28.5M | Buy |
847,646
+72,845
| +9% | +$2.57M | 0.01% | 1222 |
|
|
2016
Q1 | $24.8M | Buy |
774,801
+12,544
| +2% | +$410K | 0.01% | 1323 |
|
|
2015
Q4 | $28.5M | Buy |
762,257
+23,907
| +3% | +$904K | 0.01% | 1213 |
|
|
2015
Q3 | $28M | Sell |
738,350
-42,756
| -5% | -$1.5M | 0.01% | 1241 |
|
|
2015
Q2 | $22.3M | Sell |
781,106
-1,323
| -0.2% | -$36.9K | 0.01% | 1493 |
|
|
2015
Q1 | $21.9M | Buy |
782,429
+10,885
| +1% | +$306K | 0.01% | 1510 |
|
|
2014
Q4 | $21.3M | Sell |
771,544
-27,701
| -3% | -$686K | 0.01% | 1494 |
|
|
2014
Q3 | $17.8M | Buy |
799,245
+4,881
| +0.6% | +$124K | 0.01% | 1595 |
|
|
2014
Q2 | $23.1M | Sell |
794,364
-93,711
| -11% | -$2.5M | 0.01% | 1402 |
|
|
2014
Q1 | $25.2M | Sell |
888,075
-47,569
| -5% | -$1.57M | 0.01% | 1374 |
|
|
2013
Q4 | $36.1M | Sell |
935,644
-29,593
| -3% | -$1.06M | 0.01% | 1023 |
|
|
2013
Q3 | $32.4M | Buy |
965,237
+87,199
| +10% | +$2.78M | 0.01% | 1041 |
|
|
2013
Q2 | $27M | Buy |
+878,038
| New | +$29.4M | 0.01% | 1137 |
|
Other funds holding MDCO
Northern Trust's MDCO Position: Q1 2020 in Review
Northern Trust sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 897,455 shares — an estimated $76.2M sold.
Northern Trust first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $76.2M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Northern Trust reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Northern Trust sold 897,455 Medicines Co shares in Q1 2020, an estimated $76.2M.
- Northern Trust first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
- Northern Trust's Medicines Co position peaked at $76.2M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Northern Trust's 13F filing for Q1 2020, filed 14 May 2020.